Osmind (Series B)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$189,999,994
Company Info
Founders
Lucia Huang
Market
Healthcare & Wellness
Coinvestors
DFJ Growth,Future Ventures,Susa Ventures,General Catalyst
Company Description

Operating system centered around robust data analytics for neuropsychiatric care Osmind is the premier technology platform for breakthough mental health treatment and research.